Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

News Conference News EuroPCR 2018

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Shelley Wood

May 24, 2018

News Daily News

SORT OUT III亚组研究揭示了DES疗效随糖尿病状态的变化

Todd Neale

November 17, 2014

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Todd Neale

November 17, 2014

News Daily News

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Todd Neale

November 17, 2014

Presentation TCT 2014

Case #4: Swift and Safe DES for Side Branch Bail Out

Presenter: Evald H. Christiansen, George D. Dangas, Andrejs Erglis, Michael Maeng

September 14, 2014

Presentation TCT 2013

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

October 29, 2013

Presentation TCT 2013

Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Sten...

Presenter: Lisbeth Antonsen, Lisette Okkels Jensen, Michael Maeng, Per Thayssen, Evald H?j Christiansen, Knud N?rregaard Hansen, Anne Kaltoft, Henrik Steen Hansen, Leif Thuesen, Jens Flensted Lassen

January 31, 2013

News Daily News

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

L.A. McKeown

August 23, 2012

News Daily News

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

L.A. McKeown

August 23, 2012

Presentation

3-Year Clinical Outcomes in SORT OUT III Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

August 21, 2012

Presentation TCT 2012

Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Acute Coronary Syndromes. A Substudy of the SORT OUT IV Trial.

Presenter: Lisbeth Antonsen, Per Thayssen, Henrik Steen Hansen, Michael Maeng, Hans-Henrik Tilsted, Evald Hoej Christiansen, Knud Noerregaard Hansen, Hans Erik Boetker, Jan Ravkilde, Lars Krusell, Morten Madsen, Henrik Toft Soerensen, Leif Thuesen, Jens Flensted Lassen, Lisette Okkels Jensen

January 03, 2012

Advertisement

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

SORT OUT III亚组研究揭示了DES疗效随糖尿病状态的变化

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Case #4: Swift and Safe DES for Side Branch Bail Out

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Sten...

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

3-Year Clinical Outcomes in SORT OUT III Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Acute Coronary Syndromes. A Substudy of the SORT OUT IV Trial.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content